MedPath

Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)

Not Applicable
Completed
Conditions
Heart Failure
Interventions
Device: Triage BNP Test
Registration Number
NCT00206843
Lead Sponsor
Abbott RDx Cardiometabolic
Brief Summary

The purpose of this study is to test whether physicians can make more informed treatment, admission, and discharge decisions related to patient care by having serial Triage® BNP test results available to assess disease severity, while patients are being treated for HF in the Emergency Department and/or during their admission. This is believed to lead to a better outcome as well as more efficient and cost-effective treatment.

Detailed Description

This is a patient-randomized clinical study consisting of patients who present to the ED requiring treatment and/or admission for HF. At each site, patients will be randomized into either a control arm or an experimental arm. Serial blood samples will be collected from all patients throughout their stay in the ED and the hospital. In the experimental arm, the Triage® BNP test will be performed on all blood samples collected and each BNP result will be made available to the attending physicians immediately. In the control arm, blood samples will not be analyzed on-site for BNP but instead sent directly to Biosite Inc. for testing.A comparison will be made between the control and experimental arms of the study to determine if there are any significant differences in length of stay, re-hospitalizations, all cause mortality, BNP levels, quality of life, and costs to treat patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
630
Inclusion Criteria

Age 18 and older Patient needs treatment for HF

Exclusion Criteria

Current MI or ACS with ST deviation of 1 mm or greater Renal failure requiring dialysis Undergone hemodialysis within the last month Enrollment (Baseline) Triage® BNP concentration = 100 pg/ml or less Enrolled in any other drug trial or receiving an experimental treatment for HF.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Results availableTriage BNP Test-
Primary Outcome Measures
NameTimeMethod
Combined cardiac related re-hospitalizations and all cause mortality (14-day and 30-day)
Length of hospital stay
Secondary Outcome Measures
NameTimeMethod
Cost Effectiveness
Discharge BNP
Quality of life
Change in BNP from enrollment to discharge (ΔBNP)
Ratio of ΔBNP/length of stay

Trial Locations

Locations (10)

Detroit Receiving Hospital/Wayne State University

🇺🇸

Detroit, Michigan, United States

Sinai Grace Hospital/Wayne State

🇺🇸

Detroit, Michigan, United States

New York Methodist Hospital

🇺🇸

Brooklyn, New York, United States

Stony Brook University Hospital

🇺🇸

Stony Brook, New York, United States

Wake Forest University Baptist Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

University of California, San Diego MedicalCenter

🇺🇸

San Diego, California, United States

Duke University Hospital

🇺🇸

Durham, North Carolina, United States

Hospital of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Beaumont Hospital, Troy

🇺🇸

Troy, Michigan, United States

Chandler Regional Hospital

🇺🇸

Chandler, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath